跳至主要内容
临床试验/ACTRN12618001950257
ACTRN12618001950257
尚未招募
不适用

Implantation and signal assessment of BioMonitor III in patients with suspected arrhythmias or symptoms suggestive of arrhythmic causes

BIOTRONIK Australia Pty. Ltd.0 个研究点目标入组 45 人2018年11月30日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
BIOTRONIK Australia Pty. Ltd.
入组人数
45
状态
尚未招募
最后更新
7年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2018年11月30日
结束日期
待定
最后更新
7年前
研究类型
Interventional
性别
All

研究者

发起方
BIOTRONIK Australia Pty. Ltd.

入排标准

入选标准

  • 1\. Patient is at high risk of developing a clinically important cardiac arrhythmia; or
  • 2\. Patient is undergoing investigation for symptoms such as palpitations, pre\-syncope or syncope, that are suggestive of an underlying cardiac arrhythmia; or
  • 3\. Patient is undergoing investigation for the detection of atrial fibrillation following cryptogenic stroke; or
  • 4\. Patient is planned for AF ablative procedure or has already undergone an AF ablative procedure.
  • 5\. Patient is able to understand the nature of study and has provided written informed consent
  • 6\. Patient is willing and able to perform all follow up visits at the study site
  • 7\. Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept

排除标准

  • 1\. Patients implanted with ICD or pacemaker.
  • 2\. Patient is pregnant or breast feeding.
  • 3\. Patient is less than 18 years old.
  • 4\. Patient is participating in another interventional clinical investigation
  • 5\. Patient´s life\-expectancy is less than 6 months.

结局指标

主要结局

未指定

相似试验